Literature DB >> 2321591

Type IV Ehlers-Danlos syndrome presenting as sudden infant death.

R W Byard1, F W Keeley, C R Smith.   

Abstract

A previously healthy 5-month-old female infant presented with sudden death due to spontaneous subarachnoid hemorrhage associated with minor multifocal visceral hemorrhages. The clinical diagnosis had been sudden infant death syndrome. Although the family history was noncontributory and other features of type IV Ehlers-Danlos syndrome (EDS) were absent, the pattern of hemorrhage was consistent with this type of connective tissue disorder. The diagnosis was confirmed after postmortem analysis of skin and aorta showed less than 5% type III collagen (normal greater than 15%). Extensive literature review failed to find any other reported cases of sudden death in infancy due to intracranial hemorrhage in patients with previously unsuspected type IV EDS. The authors suggest that collagen analysis should be performed in cases of unexplained multifocal spontaneous hemorrhage in infancy so that this rare diagnosis will not be missed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2321591     DOI: 10.1093/ajcp/93.4.579

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

Review 1.  Spontaneous common iliac arteries rupture in Ehlers-Danlos syndrome type IV: report of two cases and review of the literature.

Authors:  K Habib; M A Memon; D A Reid; B J Fairbrother
Journal:  Ann R Coll Surg Engl       Date:  2001-03       Impact factor: 1.891

2.  Obesity surgery and Ehlers-Danlos syndrome: challenges and considerations based on a case report.

Authors:  I N Gerogiannis; I D Gkegkes; N J Dempster; R S Gillies; B Sgromo
Journal:  Ann R Coll Surg Engl       Date:  2019-09-18       Impact factor: 1.891

3.  Spontaneous rupture of the spleen in type IV Ehlers-Danlos syndrome: report of a case.

Authors:  Antonio Privitera; Chaz Milkhu; Vivek Datta; Mazim Sayegh; Richard Cohen; Alastair Windsor
Journal:  Surg Today       Date:  2009-01-08       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.